biztrac. BETA
COMPANY REGISTER PROFILE
915157882 ORG. NO. 2025 ACCOUNTS 7 SECTIONS
Active UPDATED 03.10.2026
Manufacture of pharmaceutical preparations

VISTIN PHARMA ASA

Org. no. 915157882 Public limited company (ASA) Oslo Listed VISTN Incorporated 2015 Active
Operating profit NOK −5.2m
Equity NOK 139.6m
Incorporated 2015
Share capital NOK 44.3m

Signals

1 flags
  • Driftsunderskudd 2025 Siste driftsresultat er negativt (−5,2 mill kr).

VISTIN PHARMA ASA is registered as a public limited company in Oslo, Oslo with organisation number 915157882. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2015. Registered share capital is NOK 44.3m, divided into 44344592 shares. The company's stated purpose is: “Utvikling, produksjon og salg av legemidler og andre helserelaterte produkter og tjenester. Dette kan også realiseres ved eierskap i andre selskaper.”.

Key figures · 2025

Operating profit
NOK −5.2m
▲ +15 %
Equity
NOK 139.6m
▼ −24 %
Est. value
NOK 146.3m

Financial health · 2025

Liquidity
34.70
Very good
Current assets ÷ current liabilities
Profitability
8.6%
Satisfactory
Return on total assets
Solidity
98.2%
Very good
Equity as a share of total capital

Who owns VISTIN PHARMA ASA?

VISTIN PHARMA ASA has 20+ registered shareholders:

All shareholders and roles →

Which companies does VISTIN PHARMA ASA own?

VISTIN PHARMA ASA holds a stake in 1 company:

See the full ownership structure →

Frequently asked questions about VISTIN PHARMA ASA

Who owns VISTIN PHARMA ASA?

INTERTRADE SHIPPING AS is the largest registered owner, with 32.7%.

Who is the general manager of VISTIN PHARMA ASA?

Magnus Wilhelm Tolleshaug is registered as general manager of VISTIN PHARMA ASA.

Where is VISTIN PHARMA ASA based?

VISTIN PHARMA ASA has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.